Huron Acquires RelateCare to Accelerate Healthcare Service Delivery
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 03 2026
0mins
Source: Newsfilter
- Acquisition Enhances Service Capabilities: Huron's acquisition of AI-driven RelateCare aims to improve patient access and care coordination, thereby enhancing the comprehensiveness and differentiation of its managed healthcare services to meet strategic demands for financial performance and patient experience.
- Technology Integration Boosts Efficiency: The combination of RelateCare's clinical expertise with advanced technology delivers an integrated model from patient scheduling to clinical triage, significantly enhancing patient and clinician engagement, further solidifying Huron's industry expertise.
- Market Expansion Potential: This acquisition allows RelateCare to scale its capabilities and market reach, and combined with Huron's resources, is expected to accelerate growth and deliver greater impact across a broader set of healthcare organizations, enhancing market competitiveness.
- Operational Integration and Financial Performance: RelateCare will be included in Huron's Healthcare operating segment, optimizing consulting and managed services capabilities, improving access efficiency and operational performance for healthcare organizations, and driving overall financial performance improvements.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HURN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HURN
Wall Street analysts forecast HURN stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 106.200
Low
207.00
Averages
211.00
High
215.00
Current: 106.200
Low
207.00
Averages
211.00
High
215.00
About HURN
Huron Consulting Group Inc. is a global professional service. The Company operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. The Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Its products include TriZetto’s Facets, QNXT, and HealthEdge solutions.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Rally: The S&P 500 rose 1.08%, the Dow Jones increased by 0.14%, and the Nasdaq 100 surged 2.48% as optimism over the US-Iran peace deal eased inflation risks, reflecting a positive market sentiment.
- Chip Sector Surge: Intel's stock jumped over 10% after President Trump announced a partnership with Apple to design and produce semiconductors domestically, leading the iShares Semiconductor ETF to rise more than 7%, indicating strong momentum in the tech sector.
- Energy Stocks Weaken: WTI crude oil prices fell to a 3.5-month low, causing significant declines in energy stocks, with SLB, ConocoPhillips, and Halliburton dropping over 3%, highlighting concerns over energy price volatility.
- Supportive Economic Data: Initial jobless claims fell to 226,000, close to the expected 225,000, indicating labor market strength, while the Philadelphia Fed business outlook index rose to 10.3, surpassing expectations, further boosting investor confidence.
See More
- Market Rebound: The signing of a preliminary deal by President Trump to end the US-Iran war has driven crude oil prices to a 3.5-month low, resulting in a broad market rally with the S&P 500 up 0.99% and the Nasdaq 100 up 2.16%, indicating a resurgence in risk appetite among investors.
- Chip Stocks Lead Gains: Intel shares surged 7% after Trump announced a partnership with Apple to design and produce semiconductors domestically, propelling the entire semiconductor sector higher, with the iShares Semiconductor ETF rising over 5%, reflecting strong investor confidence in tech stocks.
- Energy Stocks Under Pressure: Crude oil prices fell more than 3%, putting pressure on energy producers, with major companies like ExxonMobil and Chevron experiencing declines, highlighting market concerns regarding the energy sector's outlook amid falling oil prices.
- Supportive Economic Data: Initial jobless claims in the US fell to 226,000, close to the expected 225,000, indicating labor market resilience, while the Philadelphia Fed business outlook index rose to 10.3, exceeding expectations, further bolstering market optimism.
See More
- Market Rally: Following President Trump's signing of a preliminary US-Iran ceasefire agreement, the S&P 500 rose by 0.73%, the Dow Jones by 0.53%, and the Nasdaq 100 by 1.62%, reflecting a risk-on sentiment in asset markets.
- Chipmaker Surge: Intel's stock jumped 8% after Trump announced a partnership with Apple to design and produce semiconductors domestically, leading the semiconductor sector higher, with the iShares Semiconductor ETF up over 4%.
- Supportive Economic Data: Weekly initial unemployment claims fell by 4,000 to 226,000, close to the expected 225,000, while the Philadelphia Fed business outlook survey rose by 10.7 to 10.3, exceeding expectations and bolstering market confidence.
- Oil Price Decline Impact: WTI crude oil prices dropped over 2% to a new 3.5-month low, potentially releasing over 100 oil-laden tankers stuck in the Persian Gulf, which could increase market supply and influence future oil price trends.
See More
- Acquisition Enhances Service Capabilities: Huron's acquisition of AI-driven RelateCare aims to improve patient access and care coordination, thereby enhancing the comprehensiveness and differentiation of its managed healthcare services to meet strategic demands for financial performance and patient experience.
- Technology Integration Boosts Efficiency: The combination of RelateCare's clinical expertise with advanced technology delivers an integrated model from patient scheduling to clinical triage, significantly enhancing patient and clinician engagement, further solidifying Huron's industry expertise.
- Market Expansion Potential: This acquisition allows RelateCare to scale its capabilities and market reach, and combined with Huron's resources, is expected to accelerate growth and deliver greater impact across a broader set of healthcare organizations, enhancing market competitiveness.
- Operational Integration and Financial Performance: RelateCare will be included in Huron's Healthcare operating segment, optimizing consulting and managed services capabilities, improving access efficiency and operational performance for healthcare organizations, and driving overall financial performance improvements.
See More
- Complete Exit: Ophir Asset Management fully liquidated its position in Huron Consulting Group during Q1 2026, selling 244,302 shares for an estimated $36.73 million, indicating a potential loss of investor confidence in the firm.
- Market Value Decline: The transaction resulted in a $42.24 million decrease in Huron's quarter-end market value, highlighting the direct impact of market price fluctuations on the company's valuation and possibly affecting investor sentiment.
- Performance Metrics: Despite Huron's Q1 revenue rising 12.1% year-over-year to $443.7 million and adjusted EBITDA climbing nearly 22%, the stock has fallen 30%, suggesting concerns about its future growth amidst market volatility.
- Future Outlook: Huron's CEO acknowledged challenges in an AI-driven market, and while the company maintains a full-year revenue guidance of up to $1.86 billion, investors are closely watching its ability to sustain pricing power and margins as automation becomes more prevalent.
See More
- Share Reduction Transaction: Aristotle Capital sold 40,351 shares of Huron Consulting Group in Q1 2026, with an estimated trade value of approximately $6.07 million, indicating a reduction in confidence towards the company.
- Declining Share Value: As of the end of Q1 2026, Aristotle Capital held about 249,912 shares of Huron worth $31.90 million, but the net position value declined by $18.29 million during the period, reflecting weakened market confidence in Huron.
- Performance Metrics: Despite a 30% drop in stock price, Huron's Q1 2026 revenue grew 12% year-over-year to a record $443.7 million, with adjusted EBITDA rising nearly 22%, showcasing strong demand in the healthcare consulting sector.
- Future Outlook: Huron anticipates revenue of up to $1.86 billion in 2026, with healthcare accounting for 51% of total revenue, as management continues to focus on digital transformation and AI-related consulting demand, indicating potential for long-term growth.
See More











